Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or brief psychotic disorder, as confirmed by standard diagnostic guidelines (DSM-5)
- People who have never taken antipsychotic medication before, except possibly during their current episode and for less than 6 months total
- People who have given spoken agreement to take part in the study, or, for those under 18, whose parents have given spoken agreement
Who may not be able to join:
- People who are already receiving ongoing treatment and follow-up care specifically for a first psychotic episode
- People whose brief psychotic state has been assessed as not needing specific medical management
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric FAKRA, MD PhD, Centre Hospitalier Universitaire de Saint Etienne
Phone: (0)477127885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Duration of untreated psychosis (DUP)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.